RSI Oversold Bounce Stocks — Financial View · Biological Products, (No Diagnostic Substances)
5 stocks match the RSI Oversold Bounce Stocks screen. Stocks whose 14-day RSI has just crossed back above 30 out of oversold territory — a potential reversal. Financial columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–5 of 5
| GLUE | Monte Rosa Therapeutics, Inc. | $1.2B | — | -23.3% | -33.1% | -33.1% | 10.58 | 0.42 | — | — | — | 14.39 | +1.12% | 38K |
| GRML | Greenland Mines Ltd | $715M | — | -33.5% | -37.6% | -37.6% | 10.09 | 0.12 | — | — | — | 4.50 | -7.31% | 22K |
| SCLX | Scilex Holding Co | $45M | — | — | — | — | 0.07 | 0.00 | — | — | — | 5.31 | -0.56% | 2K |
| PMCB | PharmaCyte Biotech, Inc. | $5M | — | -44.0% | -58.7% | — | 40.30 | 0.01 | — | — | — | 0.49 | +1.62% | 800 |
| VIVS | VivoSim Labs, INC. | $4M | — | — | — | — | 1.70 | -2.64 | — | — | — | 0.28 | -1.01% | 8K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.